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INTRODUCTION 
Phospholipids are an integral part of most mammalian 
membranes. Phosphatidylcholine has been shown to be a major 
component of liver microsomal membranes, and the enzymes re- 
sponsible for its biosynthesis are located primarily in the 
endoplasmic reticulum. The distribution of molecular species 
appears to be related to the membrane function, regulating 
such things as transport and permeability. Unsaturation in 
the fatty acid chains increases the permeability of the mem- 
brane, the fluidity of which is usually controlled by the 
cholesterol content. 
Various drugs are known to alter lipid metabolism. The 
effects of phenobarbital, a C-5 ethyl, phenyl derivative of 
barbituric acid, and ethionine, an ethyl analogue of methio- 
nine, on phosphatidylcholine biosynthesis have been studied. 
Phenobarbital seems to decrease the catabolism of phospha- 
tidylcholine, with some reports of no changes in the percen- 
tages of the fatty acids present, and other reports that de- 
creases occur in some of the more unsaturated fatty acids 
such as arachidonic and docosahexenoic. Ethionine has been 
shown to decrease the percentage of arachidonic and docosa- 
hexenoic and increase linoleic and oleic acids. 
The isolation of phosphatidylcholine from the livers of 
drug treated animals, and the separation of the trimethylsilyl 
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diglyceride derivatives by gas chromatography can give an 
indication of the changes these drugs bring about in the syn- 
thesis of the molecular species of phosphatidylcholine. 
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STATEMENT OF THE PROBLEM 
Phenobarbital and ethionine are known to produce changes 
in phosphatidylcholine biosynthesis. Phosphatidylcholine is 
a major constituent of most mammalian membranes, and as the 
structure and function of the membrane is a product of the 
composition of the membrane, it is important to know what 
effect these drugs have on the composition of phosphatidyl- 
choline. This research is an attempt to determine the modi- 
fications in molecular species of phosphatidylcholine brought 
about by these drugs. Gas chromatography of the trimethyl- 
silyl derivatives of the diglycerides obtained from liver 
phosphatidylcholines of the treated animals will be used as 
the analytical tool. From the shifts in percentages of mole- 
cular species present, speculation about how the drugs are 
acting on the biosynthetic enzymes will be made. 
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LITERATURE REVIEW 
The discovery of phospholipids as a major constituent of 
many animal membranes has led to extensive investigations of 
their exact composition under both normal and abnormal condi- 
tions. The possibility that abnormal conditions alter the 
phospholipid composition, which in turn alters the membrane 
properties, has intrigued many scientists. The understanding 
of the normal composition and the pathways of phospholipid 
metabolism is necessary before comparison to abnormal condi- 
tions can be made. 
Phosphatidylcholine has been shown to be a major constit- 
uent of rat liver membranes (1,2), and is synthesized mainly 
by two pathways. The major one, known as the Kennedy pathway 
(3), involves the transfer of the phosphorylcholine moiety 
from cytidine diphosphate choline (CDP-choline) to a 1,2-di- 
acyl-sn-glycerol, forming phosphatidylcholine and cytidine 
monophosphate (CMP). The enzyme catalyzing this reaction is 
CDP-choline:l,2 diglyceride cholinephosphotransferase (EC.2. 
7.8.2). This pathway accounts for some 80-90% of the phos- 
phatidylcholine synthesized by the rat liver microsomes (4). 
The minor pathway, the Bremer -Greenberg pathway (5), involves 
the sequential methylation of phosphatidylethanolamine by the 
transfer of methyl groups from S-adenosyl-L-methionine to pro- 
duce phosphatidylcholine and S-adenosylhomocysteine. There 
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are two enzymes involved. One catalyzes the addition of the 
first methyl group, and the other catalyzes the last two addi- 
tions. The enzymes are referred to as S-adenosyl-L-methionine: 
phosphatidylethanolamine methyltransferases (SAME:PE methyl- 
transferase). All three enzymes are confined to the endo- 
plasmic reticulum (6,7). 
In an extensive study by Hill et al. (8), the diacyl 
subspecies of phosphatidylcholine and phosphatidylethanol- 
amine in rat liver were identified. In 1,2-diacyl-sn-gly- 
cero-3-phosphorylcholine the monoene, diene, tetraene and 
hexaene species represented 11, 28, 35, and 5 mole percent 
respectively, whereas in 1,2-diacyl-sn-glycero-3-phosphoryl- 
ethanolamine the corresponding values were 2, 19, 48, and 19 
mole percent. Furthermore, the tetraene subspecies of 3-sn- 
phosphatidylethanolamine which contained arachidonic acid 
showed a 2:1 preference for stearic over palmitic as the sat- 
urated acid in position 1. In the hexaene subspecies, the 
1:2 ratio of stearic to palmitic indicated a preference for 
palmitic acid in position 1. In both monoene and diene sub- 
species a preference for palmitic over stearic was seen. 
Lyman et al. (9) demonstrated that the fastest moving 
subfraction of phosphatidylcholine from whole rat liver on 
thin layer plates resembled the fraction of phosphatidyleth- 
anolamine. This subfraction had a higher percentage of stearic 
and arachidonic acid than the slower subfractions. Females 
had a higher percentage of this subfraction than did males. 
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These authors suggested that a large percentage of the stea- 
ric-arachidonic phosphatidylethanolamine was methylated to 
produce phosphatidylcholine, and that there was a higher rate 
of methylation in females. Lyman et al. (10) were able to 
show that estradiol was the agent that enhances the methyla- 
tion pathway. Studies by Rytter et al. (11) demonstrated 
that 14C-choline was incorporated mainly into phosphatidyl- 
choline with two or less double bonds, and 14C-ethanolamine 
was mainly incorporated into phosphatidylcholine with six 
double bonds. Arvidson (12) found that the tetraene subfrac- 
tion is dominant in both phosphatidylethanolamine and phos- 
phatidylcholine, and that the hexaene fraction was more 
prominent in phosphatidylethanolamine than phosphatidylcho- 
line. He reported that 14C-choline was incorporated most 
rapidly into 16:0, 18:1 and 16:0, 18:2 diglycerides, but 
slowly into 18:0, 20:4 diglycerides. On the other hand, 14C- 
methionine was incorporated most rapidly into the tetra- and 
hexaenoic fractions. Tinoco et al. (13) supported this work 
by showing that the subfractions with 18:2 and 20:4 in the 2 
position had 88 percent of the total radioactivity in phos- 
phatidylcholine after 14C-methionine injection into female 
rats. Kanoh (14), using this same labelled isotope, con- 
firmed that hexaenoic phosphatidylcholine was the major pro- 
duct of the methylation of phosphatidylethanolamine. 
Though the Kennedy pathway shows a preference for the 
diglycerides with two or less double bonds, Mudd et al. (15) 
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found that the enzyme exhibited no specificity for any par- 
ticular diglycerides. Van Golde et al. (16) were able to 
show that de novo synthesis produced mainly mono- and diun- 
saturated phosphatidylcholines, and that arachidonic acid was 
introduced by transacylation of lysophosphatidylcholine. Tre- 
whella and Collins (17) confirmed that the 18:0, 20:4 digly- 
ceride was formed largely via the methylation of phospha- 
tidylethanolamine to phosphatidylcholine, and that the 16:0, 
18:2 diglyceride was formed mainly by the CDP-choline pathway. 
Choline deficiency has been shown to decrease the 20:4 
fraction of phosphatidylcholine, and increase the 18:1, 18:2 
and 22:6 fractions (18). Other workers (19,20) have also in- 
dicated a decrease in 20:4 in both phosphatidylcholine and 
phosphatidylethanolamine when rats are fed a choline defi- 
cient diet. Beare -Rogers (19) reported that the percentage 
increases in 22:5 and 22:6 served as replacements for the 
20:4 in phosphatidylethanolamine, but did not become major 
constituents of phosphatidylcholine. She also reported that 
the relative distribution of 20:4 between phosphatidylethan- 
olamine and phosphatidylcholine in choline deficient animals 
remained the same as in control animals, but less phospha- 
tidylcholine was synthesized and less phosphatidylethanol- 
amine contained 20:4. Lyman et al. (20) supported these ob- 
servations by reporting that choline deficiency reduced the 
proportion of 20:4 in the phosphatidylethanolamines of ani- 
mals of both sexes, and increased the proportion of 22:5. 
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Turkki and Silvestre (21) demonstrated that choline defi- 
ciency stimulated the methylation of phosphatidylethanol- 
amine to phosphatidylcholine as measured by 14c -methionine 
incorporation. Glenn and Austin (22) showed that choline 
deficiency stimulated an increase in methylation of phos- 
phatidylethanolamine to phosphatidylcholine in both males 
and females, with males showing an increase in the activ- 
ity of SAME:PE methyltransferase after only 21 hours. Fe- 
males showed an increase in activity of this enzyme only 
after three to six weeks. Recently Skurdal and Cornatzer 
(23) found that choline deficiency produced a decrease in 
the activity of this enzyme in females, but did not alter 
the choline phosphotransferase. 
In accordance with Lyman's findings that estradiol was 
the causative agent for the increased methylation in females, 
Young (24) has demonstrated that estradiol enhanced the ac- 
tivity of SAME:PE methyltransferase in castrated male rats 
and decreased the CDP-choline:l,2 diglyceride cholinephos- 
photransferase activity. 
Just recently (25), it has been shown that the back re- 
action of the Kennedy pathway is important in the degrada- 
tion of phosphatidylcholine to form 1,2-diacyl-sn-glycerols 
which are more unsaturated than those formed from phospha- 
tidic acid. The ethanolamine phosphotransferase utilized 
mainly hexaenoic diacylglycerols to form phosphatidylethan- 
olamine, and this species was also the main species to be 
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methylated to form phosphatidylcholine. This may explain 
the observation by Arvidson (12) that the disappearance of 
14c 
-methionine label occured most rapidly in the hexaenoic 
subfraction of phosphatidylcholine. 
It is apparent that both pathways are influenced by the 
availability of substrates, donors, and the activities of 
the enzymes, and that these factors can modify the diglycer- 
ide species of phosphatidylcholine produced. 
The well-known effects of ethionine are an indication of 
the flexibility of these pathways. Simmonds et al. (26) 
showed that ethionine inhibited SAME:PE methyltransferase, 
and Stekol et al. (27) found that ethionine inhibited meth- 
-
ionine methyl incorporation into phosphatidylethanolamine to 
form phosphatidylcholine. Ulsamer and Glenn (28), and Sato 
and Hasegawa (29) reported that ethionine increased the 32P 
uptake into phosphatidylcholine and brought about a drop in 
phosphatidylethanolamine labelling in females. Lyman et al. 
(30) showed that the diglycerides were in fact changed in 
males, and reported that the percentage of arachidonic acid 
was decreased and the oleic and linoleic acid percentages 
were increased. These results are consistent with what one 
would expect if the methylation of the highly unsaturated 
phosphatidylethanolamines were inhibited. Ethionine also 
impaired the synthesis of arachidonic acid from linoleic 
acid in the desaturation reaction, thus lowering the amount 
of highly unsaturated fatty acid available for phospholipid 
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synthesis. 
The effect of phenobarbital on the pathways is not as 
well established as that of ethionine. Phenobarbital has 
many actions on the liver. It is a well-known inducer of 
many of the drug metabolizing enzymes such as dopa decar- 
boxylase (31) and aminopyrine demethylase (32). Orrenius 
and Ericsson demonstrated that phenobarbital decreased the 
activity of glucose-6-phosphatase, and enhanced the forma- 
tion of the endoplasmic reticulum (33). Phenobarbital has 
been shown to increase liver weight (32,34,35), increase 
total protein (32,36), and induce the formation of cyto- 
chrome P-450 (37,38). Cytochrome P-450 appears to be in- 
volved in the hydroxylating system of the microsomes, and 
is the binding site of the drug undergoing the reaction (37). 
Phosphatidylcholine is essential for the enzymatic reduction 
of cytochrome P-450, though it does not change the spectral 
properties or alter the binding of the substrates (39). The 
dramatic increase in the endoplasmic reticulum requires the 
synthesis of phospholipid for additional membrane. Just ex- 
actly how this phospholipid increase is brought about has 
been the subject of much controversy. 
Using an orthophosphate (32P) labelling technique, 
Orrenius et al. (40) reported that an increase in phospho- 
lipid synthesis in the liver microsomes was stimulated by 
phenobarbital. Holtzman and Gillette (41), using the same 
technique, found that the synthesis was not increased, but 
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that the accumulation was due to a decreased catabolism. 
This technique did not measure the methylation pathway or 
the conversion of lysophospholipids to phosphatidylcholine. 
Infante et al. (42) using both 32P -phosphate and 14C-palmi- 
- --- 
tate were able to show that neither the Kennedy pathway nor 
the conversion of lysophospholipids to phosphatidylcholine 
was increased by phenobarbital. Though the methylation path- 
way was not directly measurable in their study, they did re- 
port that, since they recovered more label in the phospha- 
tidylethanolamine of phenobarbital treated animals than in 
controls, it appeared that the conversion of phosphatidyl- 
ethanolamine to phosphatidylcholine may have been decreased 
by phenobarbital. Their conclusion supported that of Holtz- 
man in that a decreased catabolism appeared to be responsible 
for the phospholipid accumulation after phenobarbital treat- 
ment. Stein and Stein (43) were finally able to report that 
phenobarbital decreased the activity of acyl phosphohydrolase 
toward both phosphatidylethanolamine and phosphatidylcholine. 
They also reported that the conversion of phosphatidylethan- 
olamine to phosphatidylcholine appeared to be decreased, and 
that there was no increase in incorporation of choline or 
ethanolamine. Recently, Ericksson and Dallner (44), also 
reported that phenobarbital produced a decreased breakdown 
of phosphatidylcholine as measured by the half life of 3H - 
glycerol labelled phospholipid. 
Young et al. (45) have reported that in vitro phenobar- 
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bital increased the activity of SAME:PE methyltransferase, 
but not that of choline phosphotransferase. They also re- 
ported an increased incorporation of 3H -methyl from meth- 
ionine into phosphatidylcholine. However, Davison and Wills 
(46) have demonstrated that phenobarbital gave an increase 
in SAME:PE methyltransferase within 12 hours, but brought 
about a decrease after three days. Thus, it is still not 
well established whether phenobarbital exerts its effects 
by only a decreased catabolism, or a combination of this 
and an increased synthesis. No reports of diglyceride spe- 
cies from phenobarbital treated animals have been published, 
though reports of fatty acid composition of phospholipids 
have been. Ariyoshi et al. (47) reported that no change in 
phosphatidylcholine fatty acids was brought about, though a 
decrease in stearic acid of phosphatidylethanolamine was 
noted. Davison and Wills (48) found that linoleic acid was 
increased, and arachidonic and docosahexenoic acids were de- 
creased. If phenobarbital does enhance the methylation path- 
way, the diglycerides formed should be different than the con- 
trols. Since ethionine inhibits this pathway, the differences 
between the ethionine treated and the phenobarbital treated 
animals might be considerable. Treatment of animals with 
both drugs could produce a cancellation effect, or one treat- 
ment might predominate over the other. If phenobarbital does 
not enhance the methylation pathway, but only decreases cata- 
bolism, the diglycerides accumulated might reflect the speci- 
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ficities of the catabolic enzymes. 
The analysis of phospholipids has progressed dramati- 
cally over the last few years. Since the discovery and use 
of the phospholipases, much information has been collected. 
Treatment of the phospholipids with phospholipase A2, known 
as phosphatide acyl-hydrolase (EC.3.1.1.4), releases the 
fatty acid at position 2 of the phospholipids whether or not 
the fatty acid is unsaturated (49). Some specificity for 
different phospholipids is present depending upon the source 
of the enzyme (50). Phospholipase Al removes the fatty acid 
esterified at position 1 of the phospholipids (51), while 
phospholipase B removes the remaining fatty acid from posi- 
tion 1 or 2 of lysolecithin. It tends to remove unsaturated 
fatty acids faster than saturated ones (52). Using these 
enzymes the fatty acids at positions 1 and 2 can be deter- 
mined once the phosphatidylcholine has been purified. Using 
total phosphatidylcholine as the substrate one can measure 
the percentage of each fatty acid present at each position. 
However, this procedure does not tell which fatty acids 
occur together in one molecule. With the advent of argenta- 
tion chromatography whereby the purified phosphatidylcholine 
is chromatographed on silica gel treated with silver nitrate 
(53), subfractions can be isolated which differ in the degree 
of unsaturation of their fatty acids. These subfractions can 
then be treated with the phospholipases to distinguish which 
fatty acids predominate in each subfraction. The phospha- 
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tidylcholine can first be treated with phospholipase C to 
remove the phosphorylcholine moiety (54), and then the digly- 
cerides produced subjected to the argentation chromatography. 
However, the subfractions produced in either case are still 
heterogeneous, and one still has not been able to separate 
pure molecular species. The development of analysis of di - 
glycerides by gas liquid chromatography (GLC) has permitted 
the analysis of molecular species without degradation of the 
diglyceride. It also has the advantage of eliminating one 
chromatographic step with the possibility of loss of minor 
components, and has reduced the time involved. O'Brien and 
Klopfenstein (55) were able to separate diglycerides on 3% 
OV-1, using a glass column with a special Kovar-to-glass 
seal. This system was able to separate 1,2 from 1,3 digly- 
cerides and distinguish between unsaturation of at least two 
subfractions with a total of 36 carbons. Just recently Myher 
and Kuksis (56), using 3% Apolar-5CP, separated diglycerides 
differing in carbon number and in unsaturation. However, 
their system did not give baseline resolution of the higher 
carbon species that differed from each other in only one 
double bond. In addition, this system required an hour and 
a half for each run. Further progress in this area should 
yield faster, higher resolution systems, which will become 
significant tools in the analysis of molecular species of 
phosphoglycerides. 
EXPERIMENTAL METHODS 
Animal Treatments 
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Male Sprague Dawley rats obtained from our own colony, 
with a weight range of 217-247g for the first experiment and 
253-408g for the second experiment were used. The animals 
were weighed and grouped prior to the beginning of the in- 
jections and labelled by notching either the right, left, or 
neither ear. The animals were arranged so that all groups 
had relatively equal weight distribution, with six rats per 
group and five rats per group in the first and second experi- 
ments, respectively. They were housed three animals to a 
large cage, kept in a room maintained at constant temperature 
(720 F) with 12 hours of alternating light and dark. They 
were fed ad libitum with Purina Rat Chow (Ralston Purina Co., 
St. Louis, Mo.), and water was available at all times. One 
group of animals was injected intraperitoneally with 80 mg 
phenobarbital/kg of body weight once a day for three days, 
one group with 1 mg DL-ethionine/g of body weight divided 
into four separate doses given two hours apart on the third 
day, and one group with both drugs. Controls in both ex- 
periments received 0.9% saline containing the same concen- 
tration of propylene glycol as the phenobarbital solution. 
An additional control group in the second experiment received 
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0.9% saline with no propylene glycol added. The volume of 
saline received by the controls was proportional to the weight 
of the animal. The ethionine treated animals received 0.9% 
saline injections on the first two days of the experiment of 
a volume equal to the controls. A fresh needle (Monoject 
200, 25 gauge by 5/8 inch, Sherwood Medical Industries, Inc., 
Deland, Florida) was used for each individual injection. 
Food was removed from all animals at the beginning of the 
ethionine injections. The animals were weighed again and 
then killed by decapitation on the morning of the fourth day. 
The livers were quickly removed, placed in pre -weighed plas- 
tic bags, weighed and placed on ice. They were frozen at 
-16° C until ready for extraction. 
Preparation of Drug Solutions 
The phenobarbital solutions were prepared by diluting 
a purchased stock solution of 162 mg phenobarbital/ml of a 
propylene glycol solution (Gotham Pharmaceutical Co., Inc., 
Brooklyn, N.Y.). Dilutions were made with a sterilized 0.9% 
saline solution to produce a concentration that would deliver 
the required dosage of 80 mg/kg in less than one milliliter. 
By assuming the vehicle to be pure propylene glycol, the 
final concentration of propylene glycol in the working solu- 
tion could be calculated. 
A 0.9% saline solution was made that contained the same 
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concentration of propylene glycol as the phenobarbital solu- 
tion. The 0.9% saline solution was autoclaved at 15 psi, 
248° C for 30 minutes. 
The concentration of the ethionine (General Biochemi- 
cals, Inc., Chagrin Falls, Ohio) solution was limited by the 
low solubility of ethionine in water. Solutions of 25 mg 
ethionine/ml of 0.9% saline were prepared. In order to de- 
liver the required dosage, volumes of up to four milliliters 
were injected. 
Phosphatidylcholine Isolation 
The liver lipids were extracted according to the method 
of Folch et al. (57). The livers were homogenized in a War- 
ing 
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blender at one-half speed for one to two minutes. The 
filtrate was removed by suction filtration. This was rotary 
evaporated and the residue redissolved in chloroform:methanol 
(2:1). The extract was put into snap top vials, anhydrous 
Na2SO4 was added, the vials flushed with nitrogen and then 
stored at -16° C. Two livers were pooled for most samples 
in both experiments. 
Attempts to chromatograph these extracts on one milli- 
meter thick Silica Gel PF (Brinkman Instruments, Inc., West- 
bury, N.Y.) coated on glass plates 10 by 20 centimeters, in 
a solvent system of chloroform:methanol:water (65:25:4) re- 
sulted in overloading and inadequate separation of the lipids. 
In order to eliminate much of the neutral lipids, column 
chromatography using Bio Sil BH (Calbiochem, Los Angelos, 
Calif.) made up in chloroform:methanol (2:1) was carried out. 
A column measuring 6.5 by 2.5 cm with a glass wool plug at 
the bottom was used. Sequential solvents used were 50 ml 
chloroform, 50 ml chloroform:methanol (4:1), 50 ml chloro- 
form:methanol (1:1), 50 ml chloroform:methanol (1:4), and 50 
ml methanol. This system gave fairly good separation with a 
flow rate of one to two milliliters per minute and collec- 
tion of 10 ml fractions. Thin -layer chromatography of ali- 
quots of each fraction established that the phosphatidylcho- 
line was not eluted until fraction 10 or 11 and was complete- 
ly eluted by fraction 20. Thus fractions 10-20 were subse- 
quently collected from each sample. Chromatography in the 
chloroform:methanol:water (65:25:4) solvent system still did 
not give good separation of some of the phospholipids. A 
solvent system reported by Skipski et al. (58) was used in 
addition to using "basic" silica gel made by slurrying the 
gel in 1 mM Na2CO3. This system gave good separation of all 
the other phospholipid contaminents from phosphatidylcholine. 
The bands were revealed by inspection under ultraviolet light 
of wavelength 254 nanometers (Chromato-Vue, Model C-3, Ultra- 
violet Products, Inc., San Gabriel, Calif.). The bands were 
scraped and the phosphatidylcholine extracted from the gel 
with three washes of chloroform:methanol (2:1). The applica- 
tion of the sample to the plates, the chromatography, and the 
drying of the plates were all carried out in a nitrogen at- 
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mosphere to minimize oxidation of the lipids. 
Preparation of Diglycerides 
The extracts were evaporated to dryness under nitrogen 
and phospholipase C hydrolysis was carried out. The enzyme 
system employed 4-8 pmoles of CaC12.2H20, 2.0-4.0 mg phos- 
pholipase C (Clostridium welchii, Sigma Chemical Co., St. 
Louis, Mo.), 2-4 ml diethyl ether and 2-4 ml Tris buffer 
(pH 7.35, .02 M). It was important to dissolve the residue 
in the ether before adding the Tris buffer in order to ob- 
tain good hydrolysis. The reaction mixture was vigorously 
stirred in the dark at room temperature for 12-24 hours. A 
12 hour reaction time produced less rearrangement of the 
1,2 diglycerides to the 1,3 diglycerides than the 24 hour 
treatment. The enzyme reaction mixture was extracted with 
two washes of ether. The ether extracts were combined and 
evaporated to dryness and the residue redissolved in heptane. 
This solution was put under nitrogen and stored at -16° C. 
Preparation of Diglyceride TMS Derivatives 
The trimethylsilyl derivatives of the diglycerides ob- 
tained from the phosphatidylcholines were made by adding 
approximately .25 ml of N,0-Bis(trimethylsilyl)acetamide 
(Pierce Chemical Co., Rockford, Ill.) to .25-.50 ml of the 
20 
diglyceride solution in snap top vials. This mixture was 
allowed to react at room temperature for ten minutes, warmed 
slightly and concentrated under nitrogen. 
Gas Chromatography of TMS Derivatives 
Gas chromatography was carried out on a Barber Coleman 
5000 gas chromatograph equipped with a hydrogen flame ioni- 
zation detector, using an eight -foot by one -eighth inch 
column packed with 10% Apolar 10C (Applied Science Labs, 
State College, Pa.) on Chromosorb Q, 100/120 mesh. The 
column was operated isothermally at 265° C, with an injec- 
tor temperature of 275° C, and a detector temperature of 
3000 C, using argon as the carrier gas with a flow rate of 
40 ml/minute. An adequate volume (usually less than one pl) 
of the derivative was used for each injection. Peak areas 
were determined by triangulation. 
Gas Chromatography of Standards 
Diglyceride standards were purchased and TMS deriva- 
tives made and chromatographed as previously described. X- 
glycerol-1,2-dimyristate, X-glycerol-1,2-dipalmitate, X-gly- 
cerol-1,2-diheptadecanoate, X-glycerol-1,2-distearate, X- 
glycerol-1,2-dinonadecanoate, X-glycerol-1,2-dipalmitoleate, 
X-glycerol-1,2-dilinoleate, and X-glycerol-1,2-dilinolenate 
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were purchased from Nu-Chek Prep., Inc., Elysian, Minn. X- 
glycerol-1,2-dioleate, sn-glycerol-2-stearate-3-oleate, and 
sn-glycerol-2-stearate-3-linoleate were purchased from Ser- 
dary Research Labs, London, Ontario, Canada. The TMS deriva- 
tives were chromatographed individually and then a pooled 
sample of all the standards was chromatographed. 
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DISCUSSION 
The selection of the dosage and the duration of the 
treatment of the animals with phenobarbital was a compromise 
among the various treatments cited in the literature. Most 
treatments were from three to five days at dosages of 50-100 
mg phenobarbital/kg of body weight (32,35,38,41,42,44,45,47, 
48). Argyris and Magmis have stated that the maximum effect 
of phenobarbital on liver weight peaks after three days of 
treatment, and the increase in demethylase activity is maxi- 
mal after four days (32). The procedure employed was adequate 
to achieve the desired results, and was very similar to that 
of other workers so that comparisons of results can be made. 
The selection of the dosage and duration of ethionine treat- 
ment was made on a similar basis. Some workers (30) intro- 
duced the ethionine in the diet, whereas others (28,29,47,59) 
injected the ethionine in divided doses, to give a total dose 
of .75-1.0 mg ethionine/g of body weight. 
In order to obtain an idea of the effect of the drugs 
on the liver weight, a liver wet weight to body weight ratio 
was calculated. This ratio is more meaningful than compari- 
son of direct liver wet weight as there was a wide variation 
in body weight in some groups and between experiments which 
would also have an effect on the liver weight. The body 
weight used in these calculation was the weight obtained 
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prior to killing. As can be seen from Figure 1, all three 
drug treatments increased the ratio over that of the controls 
in both experiments. In addition, in each experiment a pat- 
tern of phenobarbital plus ethionine > ethionine >phenobarbi- 
tal >controls is seen, though the increases in all cases in 
the second experiment were not as large as in the first ex- 
periment. This may be the result of a leveling off in the 
liver growth. The animals in the second experiment were lit- 
ter mates of those in the first experiment, and thus were both 
older and heavier by the time the second experiment was car- 
ried out. It can also be seen that the phenobarbital plus 
ethionine treatment shows a slightly greater than additive 
effect. Columns I and K are the calculated ratios obtained 
by adding the increases over controls of phenobarbital and 
of ethionine. In both experiments these calculated ratios 
are less than the actual values, as depicted in columns H 
and J for the first and second experiments, respectively. 
This suggests that the drugs are acting at two different 
sites or by two different mechanisms to bring about the in- 
crease in liver weight. The identical control values shown 
by columns B and C in the second experiment indicate that 
the incorporation of propylene glycol has no effect over 
that of saline on the liver/body weight ratio. Thus, the 
propylene glycol in the phenobarbital solution does not ex- 
ert any additional effect to that of the phenobarbital. 
The procedures used in this research to isolate and 
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Figure 1. Liver wet weight to body weight ratios of treated animals. 
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prepare the diglycerides from the phosphatidylcholines of 
drug treated rats were very successful. The column chroma- 
tography of the total liver lipid extract gave good separa- 
tion of the neutral lipids from the phospholipids. Accord- 
ing to Ansell et al. (60), the separation of the phospholipids 
into classes by column chromatography has not yet been achiev- 
ed, though some partial separation is possible. Thin layer 
chromatography, however, does give clean separation of the 
classes. There are many solvent systems available, though 
the one used by Skipski et al. (61) gives better separation 
of phosphatidylethanolamine, phosphatidylserine, phosphatidyl- 
inositol, sphingomyelin, and lysophosphatidylcholine from 
phosphatidylcholine than other commonly used systems. The use 
of basic silica gel appears to play an important role in this 
separation. The base may act to "titrate" the more acidic 
phospholipids as they move up the plate, increasing the over- 
all charge on the molecule, or the base could be titrating the 
acetic acid as it moves up the plate. Phosphatidylcholine 
does not have a group which is titratable under these condi- 
tions. The Rf values reported for this solvent system are 
.79 for phosphatidylethanolamine, .59 for phosphatidylserine, 
.48 for phosphatidylinositol, .32 for phosphatidylcholine, 
.19 for sphingomyelin, and .10 for lysophosphatidylcholine 
(60). Values calculated from sample plates fell within this 
range, with values generally running for phosphatidyl- 
ethanolamine, .62 for phosphatidylserine, .31 for phospha- 
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Figure 2. Thin layer chromatograph of the phospholipids 
of rat liver 
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tidylcholine and .18 for sphingomyelin. A drawing of a re- 
presentative thin layer separation of the column eluate is 
seen in Figure 2. The phosphatidylcholine bands were quite 
broad and some separation into subclasses was occuring, as 
was also reported by Lyman et al. (9). It was therefore im- 
portant to scrape the bands as quantitatively as possible 
and this was checked by exposing the scraped plates to iodine 
vapors. Failure to obtain a representative sample could 
cause an apparent change in the composition. 
The chromatography of the diglycerides obtained after 
phospholipase C hydrolysis to separate 1,2 from 1,3 diglycer- 
ides was eliminated because, after only a 12 hour reaction, 
the production of the 1,3 diglycerides was minor and the GLC 
of the TMS derivatives did not give split peaks or in any way 
indicate the presence of 1,3 diglycerides contaminating the 
1,2 diglycerides. 
The weakest point in the attainment of the results was 
the reliability of the gas chromatography. The character- 
istics of the column material varied whether obtained from 
the same or a different supplier. The original plan to use 
3% OV-1 on Gas Chromosorb Q 100/120 mesh was abandoned when 
this failed to give baseline resolution of the two subfrac- 
tions of the 36 carbon species as had previously been obtained 
(59). In a personal communication with J. F. O'Brien it was 
suggested to try the 3% Apolar-1OC packing material. The 
10% Apolar-lOC was tried on the assumption that it might 
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give better resolution, and it did. This material gave base- 
line resolution of several molecular species of both 34 and 
36 carbons differing in the number of double bonds, and it 
gave better resolution and faster chromatographic times than 
the recently reported system of Myher and Kuksis (56) using 
3% Apolar-5CP, although the general pattern of resolution was 
similar. 
The retention times of the standards indicate that the 
retention is indeed a function of not only the number but 
also the distribution of the double bonds in the molecule. 
This can be seen most vividly by referring to Figure 3. The 
retention information is also shown in Table 1. It is evi- 
dent that the standards 18:0, 18:1; 18:1, 18:1; and 18:0, 18:2 
are all resolved from one another. All these molecular spe- 
cies have a total of 36 carbons and differ from each other 
only in the number or distribution of the double bonds. The 
resolution of 18:0, 18:1 from 18:1, 18:1 and 18:0, 18:2 is 
quite remarkable. Even more striking however, is the resolu- 
tion of 18:1, 18:1 from 18:0, 18:2. These species not only 
have the same total carbon number, but also have the same 
number of double bonds. They differ only in the distribution 
of the double bonds within the molecule, the former having one 
double bond in each chain and the latter having both double 
bonds in the same chain. It will also be noted from this 
table that two double bonds, one in each chain, appears to 
have about the same effect on retention time as the addition 
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Table 1. Retention of commercial diglyceride 
standards 
CARBON 
SPECIES* 
FATTY 
ACIDS 
PRESENT 
RETENTION° 
(cm) 
RETENTION* 
(cm) 
28:0+ 14:0,14:0 4.4 3.5 
32:0 16:0,16:0 7.6 5.8 
32:2 16:1,16:1 10.1 7.7 
34:0 17:0,17:0 10.1 7.3 
36:0 18:0,18:0 13.6 9.7 
36:1 18:0,18:1 14.9 10.7 
36:2 18:1,18:1 16.7 12.0 
38:0 19:0,19:0 18.2 12.9 
36:2 18:0,18:2 20.3 14.7 
36:4 18:2,18:2 23.0 17.0 
36:6 18:3,18:3 33.2 23.7 
*Only carbons of the two fatty acids are included 
+The number before the colon indicates the number 
of carbons present in the two fatty acids, and 
the number after refers to the number of double 
bonds. 
°Column temperature at 257° C, flow rate of 75 ml/min. 
pooled standards chromatographed 
4Column temperature at 2650 C, flow rate of 40 ml/min. 
individual standards chromatographed 
Figure 3. Gas chromatograph of commercial diglyceride 
standards° 
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of two carbons to the corresponding saturated diglyceride. 
This can be seen by comparing 16:1, 16:1 with 17:0, 17:0, and 
18:1, 18:1 with 19:0, 19:0, in the last column of Table 1. 
The 18:1, 18:1 was separated from the 19:0, 19:0 by lowering 
the column temperature and increasing the flow rate as shown 
in the third column of Table 1, and in Figure 3. This pro- 
cedure did not separate the 32:2 from the 34:0 however. 
The resolution of the samples is better than previously 
reported for the intact molecular species. Identification of 
the peaks was possible using the standards, and knowing what 
the reported major species were. Though no standards of 16:0, 
18:1 or 16:0, 18:2 were available, the identification of 
these peaks was aided by observing that their retention times 
were similar to that of 18:0, 18:0. As noted previously, two 
double bonds have about the same retention effect as two addi- 
tional carbon atoms, and so one would expect 16:0, 18:2 to 
be similar in retention time to 18:0, 18:0. The fact that 
the 16:0, 18:2 was faster than the 18:0, 18:0 and also that 
it was known that 16:0, 18:1 and 16:0, 18:2 are major com- 
ponents, whereas 18:0, 18:0 is not, helped in identifying 
these peaks. Peak identification was hampered by the fact 
that a linear response of carbon number with retention time 
does not hold for this system as it does for methyl esters 
on polar liquid phases and diglycerides on 3% OV-1 (59). 
Thus, graphs of retention times for saturates, monoenes, 
dienes, tetraenes could not be constructed from the standards. 
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The identity of some of the minor components could not be 
determined with certainty because standards were not avail- 
able. 
It appears that this system has two major drawbacks. 
First, the hexaene species are retained quite tightly. Again, 
noting from the retention times of the standards, as the dis- 
tribution of the double bonds shifts to a preponderance in 
one chain, the retention time increases. Thus, as 18:0, 18:2 
is retained longer than 18:1, 18:1, it would appear that a 
16:0, 22:6 should be retained longer than an 18:3, 18:3 as it 
has two additional carbons and the six double bonds occur in 
one chain. Thus, even though the 18:3, 18:3 did eventually 
come through, no indication of a 16:0, 22:6 peak appeared on 
any of the samples. Myher and Kuksis (56) did report that 
their system did elute the 16:0, 22:6, but the 18:0, 22:6 was 
lost. As the packing material used in this experiment is 
roughly twice as polar and exhibits a stronger retention of 
double bonds, one might expect that the 16:0, 22:6 would not 
be eluted by the system used in this research. The other draw- 
back to this system is the short lifetime of the column. 
After a three day conditioning period a column would give 
good chromatograms for only four to six days. Peak shapes 
then deteriorated and resolution rapidly became unacceptable. 
As the samples were stored over a period of months, 
a check for autoxidation (62) was made on a number of random 
samples. No evidence of autoxidation appeared. As a further 
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check, the procedure was carried through from liver excision 
to gas chromatography within a 24 -hour period, and the results 
obtained were similar to the control results, again indicating 
no significant effect of stor'ge. 
A comparison of the control values with others reported 
in the literature for individual molecular species is limited, 
since quantitation of such species has been up to now only 
limitedly achieved by reverse phase partition chromatography. 
Two recent reports can be cited, however. Dyatlovitskaya 
et al. (63) and Myher and Kuksis (56) reported values for all 
the major and some minor molecular species of phosphatidyl- 
cholines from normal rat liver. Discrepancies between their 
data and the data shown in Table 2 are apparent and so the 
correctness of the percentages of each molecular species in 
Table 2 is not discernable. The major differences occur in 
the species 16:0, 18:2 and 18:0, 18:2. The comparison of the 
control values obtained in this research to those of others 
will show a difference because no hexaene species were deter- 
mined. The percentages of the other species will be artifi- 
cially increased by the omission of the hexaene species. This 
may account for the differences seen in the 16:0, 18:2 and 
18:0, 18:2 species. 
By grouping the percentages according to monoene, diene, 
and tetraene, more comparisons can be made. Comparisons of 
the hexaene species cannot be made. Widespread agreement 
of the percent composition of the monoene subfraction is found. 
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Table 2. Percentages of the molecular species 
of phosphatidylcholines after the 
appropriate drug treatment. 
MOLE- 
CULAR 
SPECIES 
CONTROL ETHIO- NINE 
PHENO- 
BARBITAL 
ETHIO- 
NINE 
plus 
PflENO- 
BARBITAL 
16:0,16:0 2.2+.7 2.1.3 .7*.6 1.1i.4 
16:0,16:1 .6±.2 .9+.2 1.1i.5 1.4±1.0 
--- 
-71.4 .61.3 .8±.6 1.2±.7 
16:0,18:1 9.411.0 9.2±.5 7.2+2.0 8.6±1.6 
16:0,18:2 26.3±1.1 39.212.4 27.312.3 32.510 
18:0,18:1 2.01.5 3.21.5 2.41.1 3.5±2.4 
18:0,18:2 12.4+1.8 19.8±1.4 15.111.8 21.0±1.2 
16:0,20:4 22.4*3.7 15.0±1.2 18.413.1 16.2±1.8 
--- 1.61.9 1.81.5 4.4+.4 2.14.2 
18:0,20:4 20.5±1.6 9.3±.9 16.6±1.1 12.213.7 
--- 2.9+t.3 n.p. 2.6+.9 n.p. 
---Indicates that a determination of the identity 
of the peak was not possible 
n.p. not present 
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Several groups (8,12,14,63) all report 11% monoenes, with 
Lyman et al. (10,20) reporting 8.5 and 9.8%. Combining the 
16:0, 18:1 and 18:0, 18:1 percentages of Table 2 gives 11.4% 
for the monoenes. Reported values for dienes are 28% (8), 
25% (12), 23.5% (14), 31% (63), 30.7% (10), and 22.5% (20). 
The data of 16:0, 18:2 and 18:0, 18:2 from Table 2 gives a 
somewhat higher value of 38.7%. Values for the tetraene 
species show even wider variations with values from 35% (8) 
to 58.2% (10) being reported. The data for 16:0, 20:4 and 
18:0, 20:4 give a 42.9% value that falls in the middle of 
the reported values. These results seem to indicate that 
the values for the monoenes and tetraenes are within the 
proper limits, while the dienes appear to have somewhat 
higher values than most reports. Hexaene values have been 
reported from 5% (8) to 16% (20). 
By examining the data in Table 2 and comparing Figures 
4 and 5 it is seen that ethionine treatment increases the 
percentages of 16:0, 18:2 and 18:0, 18:2 while decreasing 
those of 16:0, 20:4 and 18:0, 20:4. This is in good agree- 
ment with the results reported by Lyman et al. (30,64). 
They found that ethionine reduced the percentage of arachi- 
donic below control levels in both males and females, while 
elevating the percentage of linoleic. In males oleic acid 
was also increased. Ariyoshi et al. (47) also reported that 
ethionine decreased arachidonic and increased linoleic acid 
in female phosphatidylcholines. Ethionine as an inhibitor 
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of the methylation pathway should decrease the amount of 
phosphatidylcholine synthesized by this pathway. Ethionine 
appears to be acting at other sites also. Ulsamer and Glenn 
(28) had earlier shown that ethionine decreases the incorpora- 
tion of 32P orthophosphate into phosphatidylethanolamine and 
increases the incorporation into phosphatidylcholine. They 
also demonstrated that normal rats rapidly incorporate the 
label into phosphatidylethanolamine, but it is only slowly 
incorporated into phosphatidylcholine. They suggested that 
ethionine decreases the synthesis of phosphatidylethanolamine 
and stimulates the synthesis of phosphatidylcholine. Sato 
and Hasegawa (29) speculate that the decreased labelling 
into phosphatidylethanolamine is a result of decreased syn- 
thesis of phosphatidylethanolamine from ethanolamine. This 
is brought about by feedback inhibition of phosphatidyleth- 
anolamine due to its decreased conversion to phosphatidyl- 
choline. They also suggest that the synthesis of phospha- 
tidylcholine via the Kennedy pathway is stimulated as a com- 
pensatory mechanism. Furthermore, Lyman et al. (30) demon- 
strated that ethionine appeared to decrease the desatura- 
tion reaction in the conversion of linoleic to arachidonic 
acid. All these effects would contribute to the increase 
in linoleic acid and the decrease in arachidonic acid brought 
about by ethionine. 
The change in percentage of the fatty acids caused by 
ethionine would lead one to suggest that the species con- 
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taining arachidonic acid are formed mainly via the methyla- 
tion pathway. The literature also suggests that the hexaene 
fraction may be more dependent upon the methylation pathway 
than the tetraene fraction in the synthesis of phosphatidyl- 
choline. Lyman et al. (9) reported that the fatty acid com- 
position of the two fastest moving phosphatidylcholine frac- 
tions on thin layer plates resembled the distributions in 
phosphatidylethanolamine, and they contained more arachidonic 
and less linoleic than the slower moving phosphatidylcholine 
fraction. Administration of 14C-methionine to females showed 
that the phosphatidylcholine subfractions containing arachi- 
donic acid preferentially incorporated the label. Later, 
Lyman et al. (10) reported that estradiol given to castrated 
male rats injected with 14C-methionine incorporated more la- 
bel than controls, and the largest part of the label appeared 
in the tetraene subfraction. This subfraction contained the 
hexaene species also. Analysis of the fatty acids in phospha- 
tidylcholine showed that estradiol increased the percentage 
of the polyenoic fatty acids (22:5, 22:6), but did not alter 
the percentage of arachidonic acid. Estradiol also decreased 
the percentage of 16:0 and 18:2. The effects of estradiol and 
ethionine on the methylation pathway are antagonistic and the 
percentages of certain fatty acids reflect these effects. 
Estradiol also appears to affect the synthesis of phospha- 
tidylethanolamine in addition to its conversion to phospha- 
tidylcholine. BjOrnstad and Bremer (4) had previously re- 
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ported that females incorporate more ethanolamine into their 
phosphatidylethanolamine and phosphatidylcholine than males, 
presumably due to the effect of estradiol. In castrated 
males, estradiol decreased the percentage of linoleic and 
increased the 22:5 and 22:6 acids in phosphatidylethanolamine 
(10). Other workers (11,12,14) also demonstrated by incor- 
14 poration studies of 1}C-ethanolamine and C-methionine that 
the hexaene fraction of phosphatidylcholine appeared to be 
preferentially labelled. It thus appears that the hexaene 
subfraction of phosphatidylethanolamine is the major methyla- 
tion substrate, and if ethionine is decreasing the synthesis 
of phosphatidylcholine by this pathway, a decrease in this 
fraction should be seen. Unfortunately, the system used in 
this research did not elute the hexaene fraction and so no 
conclusions as to its fate can be made. 
As Young et al. (45) had reported that phenobarbital 
increased the specific activity of SAME:PE methyltransferase, 
it was speculated that the diglycerides produced would reflect 
the enhancement of this pathway and an increase in species 
containing arachidonic and docosahexenoic acids and a decrease 
in diglycerides with linoleic acid might be the result. How- 
ever, the data in Table 2 do not support this speculation. 
The data demonstrate that phenobarbital decreases 16:0, 20:4 
and 18:0, 20:4; increases 18:0, 18:2; and does not alter 
16:0, 18:1 and 16:0, 18:2. This data is in agreement with 
that of Davison and Wills (48) who reported an increase in 
4o 
linoleic and a decrease in arachidonic and docosahexenoic acids. 
Again, the effect of phenobarbital on the 16:0, 22:6 and 18:0, 
22:6 species is open to question as these were not eluted 
from the column. From the data of Davison and Wills, one might 
predict that the docosahexenoic species would be decreased in 
relation to controls. Ariyoshi et al. (47) did not report 
any change in the fatty acids after phenobarbital treatment. 
A sex difference may be the cause as they used females, and 
males were used in this study and the one by Davison and Wills. 
The data in Table 2 do not support the observation that 
the methylation pathway is increased by phenobarbital as 
reported by Young et al. (45). Davison and Wills (46) were 
able to report that phenobarbital did cause an increase in the 
specific activity of SAME:PE methyltransferase after 12 hours, 
but the activity returned to normal after two days of treat- 
ment and fell below normal after three days of treatment. 
Various other workers (41,42,43,44), though not measuring the 
methylation pathway directly, have concluded that phenobarbi- 
tal decreased the conversion of phosphatidylethanolamine to 
phosphatidylcholine. The data in Table 2 is consistent with 
a decrease in the methylation pathway brought about by pheno- 
barbital. However, comparison of the percentages of the mole- 
cular species between ethionine and phenobarbital demonstrate 
that they are not acting in the same direction and are not of 
the same magnitude in many cases. The effect on the molecu- 
lar species produced by both drugs bears this out. Compari- 
Figure 4. Gas chromatograph of the 1,2 diglyceride TMS 
derivatives of the phosphatidylcholines from 
the rat liver of a control animal. 
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Figure 5. Gas chromatograph of the 1,2 diglyceride TMS 
derivatives of the phosphatidylcholines from 
the rat liver of an ethionine treated animal. 
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Figure 6. Gas chromatograph of the 1,2 diglyceride TMS 
derivatives of the phosphatidylcholines from 
the rat liver of a phenobarbital treated 
animal. 
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Figure 7. Gas chromatograph of the 1,2 diglyceride TNS 
derivatives of the phosphatidylcholines from 
the rat liver of an ethionine and phenobarbi- 
tal treated animal. 
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son of Figures 4, 5, 6, and 7, in addition to the values in 
Table 2, demonstrate the differing effects of the drugs. In 
the 16:0, 18:2 diglyceride ethionine increased, whereas pheno- 
barbital did not alter the percentage as compared to controls. 
The phenobarbital plus ethionine treatment showed an increase, 
but the value was intermediate between that of the ethionine 
and that of the phenobarbital alone values. In both 16:0, 
20:4 and 18:0, 20:4 species both phenobarbital and ethionine 
brought about a decrease, but with phenobarbital exerting a 
much smaller effect. The double treated animals showed de- 
creased values intermediate between the phenobarbital and 
ethionine values. Two exceptions to these trends are seen in 
the 18:0, 18:1 and 18:0, 18:2 species. In both cases, pheno- 
barbital and ethionine bring about an increase and the double 
treated animals show an even greater increase reflecting an 
additive effect of the two treatments. 
The explanation of the results is not straightforward. 
Numerous investigators have established that phenobarbital 
decreased the catabolism of phosphatidylcholine, thus bringing 
about its accumulation. Kanoh and Ohno (25) have recently 
shown that the reaction of CDP-choline:1,2 diglyceride 
cholinephosphotransferase is important in the degradation 
of the phosphatidylcholines. The enzyme does not show a 
specificity for any particular species but produces 1,2 
diglycerides that are more unsaturated than those produced 
by phosphatidic acid. However, the CDP-ethanolamine:1,2 di- 
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glyceride ethanolaminephosphotransferase is not readily re- 
versible (4), and it does exhibit a specificity for the hex- 
aene species (25). A decrease in the activity of this enzyme 
would decrease the use of the hexaene species for the synthe- 
sis of phosphatidylethanolamine, and would possibly decrease 
the degradation of this species by the CDP-choline pathway 
due to feedback inhibition. The combination of these path- 
ways may account for the observation by Arvidson (12) that 
under normal conditions the hexaene phosphatidylcholines 
lost the 14C -methyl label most rapidly. Phospholipase B is 
known to hydrolyze the unsaturated fatty acids faster than 
the saturated ones from either position 1 or 2. It also 
deacylates phosphatidylethanolamine faster than phosphatidyl- 
choline (52). Decreases in the activities of these enzymes 
should cause an increase in the species with more unsaturated 
fatty acids. The combination of the decreased methylation 
pathway which would decrease the tetraene and hexaene species 
of phosphatidylcholine, and the decreased catabolism of these 
same species which would lead to their increase appears to 
explain the results produced by phenobarbital. 
The intermediate values of the phenobarbital plus eth- 
ionine treatment can also be explained by the same hypothesis. 
Even though both ethionine and phenobarbital have decreased 
the methylation pathway, the added effect of phenobarbital 
on the catabolic enzymes would tend to raise the decreased 
level of the polyenoic species as is seen from the data. 
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The additive effects of phenobarbital and ethionine on the 
increases of 18:0, 18:2 and 18:0, 18:1 can also be explained 
by the decreased catabolic enzymes toward all subspecies. 
The ethionine increases the formation of phosphatidylcholine 
by the CDP-choline pathway, and though phenobarbital does 
not appear to alter the synthesis of phosphatidylcholine by 
this pathway, the increase seen is due to the decreased 
effect of the catabolic enzymes. The double treated animals 
have both an increased synthesis and a decreased catabolism 
to give the additive effect. The pattern of the 16:0, 18:2 
is harder to explain. The increase by ethionine is due to 
the increased synthesis, while phenobarbital does not alter 
the percentage, possibly because the catabolic enzymes are 
still active toward this species. This would explain again 
the intermediate value of the double treated animals. 
Due to the inability of this system to elute the hexa- 
ene fractions, the percentage of the other fractions may be 
somewhat high. The small percentage of that fraction will 
not alter the other percentages excessively, however. The 
larger the initial amount of a fraction, the greater the 
increase in percentage will occur due to the deletion of 
the hexaene fraction. As the 16:0, 18:2 peak was the lar- 
gest and the 18:0, 18:2 peak was the fourth largest, this 
may explain why the comparison of diene values showed the 
results from this research to be higher than other reported 
values. The same would hold for the tetraene fraction. 
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If the hypothesis suggested to account for the changes 
in diglyceride species brought about by the drug treatments 
is true, one would predict that the hexaene species would be 
decreased in all the drug treatments. 
Development of systems that will elute the hexaene di - 
glycerides is needed before adequate conclusions about the 
effects of phenobarbital can be made. 
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SUMMARY 
The diglyceride species of phosphatidylcholines from 
male rat liver after treatment of the animal with ethionine, 
phenobarbital or both drugs were determined using gas chroma- 
tography on 10% Apolar 10C. Ethionine reduced the percentages 
of the 16:0, 20:4 and 18:0, 20:4 diglycerides, while increas- 
ing those of the 16:0, 18:2 and 18:0, 18:2. Phenobarbital 
did not alter the 16:0, 18:2, reduced the 16:0, 20:4 and 18:0, 
20:4, and increased the 18:0, 18:2 diglycerides, though not 
as drastically as ethionine. Treatment with both drugs pro- 
duced intermediate values in all cases except for the 18:0, 
18:1 and 18:0, 18:2 diglycerides, where additive effects were 
seen. It was concluded that phenobarbital decreases the 
methylation pathway and the activities of the catabolic en- 
zymes to bring about the alterations in diglyceride species. 
The intermediate and additive values for the ethionine plus 
phenobarbital treated animals can be explained by the coun- 
terbalance produced by the large decrease in the methylation 
pathway by ethionine and the decreased activity of the cata- 
bolic enzymes by phenobarbital. 
The diglyceride species were prepared by phospholipase 
C hydrolysis of the purified phosphatidylcholines. TMS de- 
rivatives were made and used for the gas chromatographic 
procedure. The system used gave good baseline resolution of 
511 
all the major diglyceride species, except for the hexaene 
species which were rot eluted. 
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Male rats were treated by injection with ethionine, 
phenobarbital, or with both drugs. The livers were re- 
moved, and the lipids extracted according to Folch et al. 
(57). The phosphatidylcholines were isolated by column 
and thin layer chromatography, and the diglycerides pre- 
pared by phospholipase C hydrolysis. Trimethylsilyl de- 
rivatives were made of these diglycerides and separated 
by gas chromatography. An 8 foot by 1/8 inch glass column 
packed with 10% Apolar 10C on Chromosorb Q 100/120 mesh, 
and operated isothermally at 265° C was used. Baseline 
resolution of all the major diglyceride species was achieved, 
except for the hexaene fraction which was not eluted. Re- 
solution that distinguished not only between the number of 
carbon atoms and double bonds within the diglyceride, but 
also in the distribution of the double bonds within the 
molecule was attained. 
Ethionine was found to decrease the percentages of 
the 16:0, 20:4 and 18:0, 20:4 diglycerides, and increase 
those of 16:0, 18:2 and 18:0, 18:2 largely by decreasing 
the methylation of phosphatidylethanolarnine to produce 
phosphatidylcholine. Phenobarbital did not alter 16:0, 
18:1 or 16:0, 18:2, decreased 16:0, 20:4 and 18:0, 20:4, 
and increased 18:0, 18:2. The changes seen were not as 
large as those brought about by ethionine. It is suggested 
that phenobarbital alters the molecular species by both 
decreasing the methylation pathway and by decreasing the 
activities of some of the catabolic enzymes. Treatment 
with both ethionine and phenobarbital produced intermedi- 
ate values in the 16:0, 18:2; 16:0, 20:4; and 18:0, 20:4 
diglycerides. Additive effects were seen in the 18:0, 18:1 
and 18:0, 18:2 diglycerides. These effects are a result 
of the counter balance between the decreased methylation 
pathway brought about by both drugs, and the decrease in 
the activities of the catabolic enzymes brought about by 
phenobarbital. 
